Literature DB >> 25256168

CD123, the plasmacytoid dendritic cell phenotypic marker, is abundant in leprosy type 1 reaction.

P R Andrade1, T P Amadeu, J A Nery, R O Pinheiro, E N Sarno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25256168     DOI： 10.1111/bjd.13430

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

2.  Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.

Authors:  Luciana Nahar Dos Santos; Pedro Henrique Lopes da Silva; Iris Maria Peixoto Alvim; José Augusto da Costa Nery; Flávio Alves Lara; Euzenir Nunes Sarno; Danuza Esquenazi
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

3.  The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.

Authors:  Thabatta Leal Silveira Andrezo Rosa; Mayara Abud Mendes; Natasha Ribeiro Cardoso Linhares; Thais Fernanda Rodrigues; André Alves Dias; Thyago Leal-Calvo; Mariana Gandini; Helen Ferreira; Fabrício da Mota Ramalho Costa; Anna Maria Sales; Thaís Porto Amadeu; Veronica Schmitz; Roberta Olmo Pinheiro; Luciana Silva Rodrigues; Milton Ozório Moraes; Maria Cristina Vidal Pessolani
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 4.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.